| Financial Year |
March 31 2023 |
| Monetary Funds |
733,510,092.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
85,201,743.24 |
| Accounts Receivable |
1,611,884,882.33 |
| Advances to Suppliers |
30,939,560.99 |
| Other Receivables |
101,071,475.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
952,786,981.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
265,028,592.44 |
| Total Current Assets |
4,186,921,842.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
288,006,496.17 |
| Investment Properties |
-- |
| Fixed Assetes |
525,648,686.91 |
| Under-construction Projects |
204,513,760.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,433,075,835.77 |
| R&D expenses |
469,490,915.32 |
| Goodwill |
541,068,982.24 |
| Long-Term Deferred and Prepaid Expenses |
17,720,938.39 |
| Deferred Income Tax Assets |
151,004,308.71 |
| Other Non-Current Assets |
371,734.29 |
| Sub-Total of Non-Current Assets |
3,915,576,112.84 |
| Total Assets |
8,102,497,954.90 |
| Short-Term Loans |
407,976,165.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
46,160,398.00 |
| Accounts Payable |
61,819,974.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
60,301,432.75 |
| Taxes Payable |
24,689,645.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
66,075,685.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,291,120.07 |
| Other Current Liabilities |
47,488,204.48 |
| Sub-Total of Current Liabilities |
1,009,887,654.97 |
| Long-term Loans |
343,909,050.38 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
34,415,501.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
501,874,057.95 |
| Total Liabilities |
1,511,761,712.92 |
| Paid-In Capital(Or Share Stock) |
1,152,381,437.00 |
| Capital Surplus |
2,825,084,603.28 |
| Surplus Reserve |
192,827,252.25 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,376,966,170.81 |
| Minority Stockholder's Interest |
43,476,778.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,547,259,463.34 |
| Owner's Equity（Stockholder's Equity） |
6,590,736,241.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,102,497,954.90 |
